{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:41:52Z","timestamp":1790242912220,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jpag.2014.08.007","type":"journal-article","created":{"date-parts":[[2014,8,17]],"date-time":"2014-08-17T08:30:15Z","timestamp":1408264215000},"page":"249-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Plasma Visfatin Levels in Adolescents with Polycystic Ovary Syndrome: A Prospective Case-Control Study"],"prefix":"10.1016","volume":"28","author":[{"given":"\u00dclker","family":"G\u00fcm\u00fc\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Irfan","family":"G\u00fczel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Onur","family":"Topcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Timur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiye","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Dan\u0131\u015fman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpag.2014.08.007_bib1","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1203\/00006450-199512000-00024","article-title":"Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence","volume":"38","author":"Venturoli","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpag.2014.08.007_bib2","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2014.08.007_bib3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2014.08.007_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2014.08.007_bib5","doi-asserted-by":"crossref","first-page":"201.e1","DOI":"10.1016\/j.ajog.2010.03.008","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"203","author":"Carmina","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jpag.2014.08.007_bib6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/aogs.12247","article-title":"Elevated serum levels of anti-Mullerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome","volume":"92","author":"Sahmay","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jpag.2014.08.007_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1757-2215-7-18","article-title":"Association between circulating adiponectin levels and polycystic ovarian syndrome","volume":"7","author":"Mirza","year":"2014","journal-title":"J Ovar Res"},{"key":"10.1016\/j.jpag.2014.08.007_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.gene.2013.05.074","article-title":"Relationship between leptin receptor and polycystic ovary syndrome","volume":"527","author":"Li","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.jpag.2014.08.007_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/09513590.2011.650749","article-title":"Serum visfatin levels in women with polycystic ovary syndrome","volume":"28","author":"Guducu","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jpag.2014.08.007_bib10","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2014.08.007_bib11","first-page":"2694","article-title":"A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome","volume":"83","author":"Legro","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2014.08.007_bib12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.2003-031205","article-title":"Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome","volume":"89","author":"Diamanti-Kandarakis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2014.08.007_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpag.2014.08.007_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpag.2007.01.001","article-title":"Polycystic ovary syndrome in adolescents","volume":"20","author":"Khan","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jpag.2014.08.007_bib15","first-page":"1431","article-title":"Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor","volume":"14","author":"Samal","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jpag.2014.08.007_bib16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jpag.2014.08.007_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1126\/science.1106933","article-title":"Medicine. Visfatin: a new adipokine","volume":"307","author":"Hug","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jpag.2014.08.007_bib18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.jpag.2014.08.007_bib19","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2014.08.007_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpag.2014.08.007_bib21","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2014.08.007_bib22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2014.08.007_bib23","doi-asserted-by":"crossref","first-page":"e496","DOI":"10.1542\/peds.2008-2050","article-title":"Glucose metabolism in overweight Hispanic adolescents with and without polycystic ovary syndrome","volume":"124","author":"Nur","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpag.2014.08.007_bib24","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1210\/jc.2006-0936","article-title":"Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin","volume":"91","author":"Tan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2014.08.007_bib25","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/humrep\/der267","article-title":"Expression of visfatin mRNA in peripheral blood mononuclear cells is not correlated with visfatin mRNA in omental adipose tissue in women with polycystic ovary syndrome","volume":"26","author":"Seow","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2014.08.007_bib26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fertnstert.2009.04.055","article-title":"Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation","volume":"94","author":"Plati","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2014.08.007_bib27","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/humrep\/dem118","article-title":"Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome","volume":"22","author":"Kowalska","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2014.08.007_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ejim.2007.05.014","article-title":"Plasma visfatin levels in normal weight women with polycystic ovary syndrome","volume":"19","author":"Panidis","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jpag.2014.08.007_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.fertnstert.2006.11.120","article-title":"Increased plasma visfatin concentrations in women with polycystic ovary syndrome","volume":"88","author":"Chan","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2014.08.007_bib30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.fertnstert.2008.10.058","article-title":"Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome","volume":"93","author":"Ozkaya","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2014.08.007_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.5114\/aoms.2012.28547","article-title":"Circulating visfatin level and visfatin\/insulin ratio in obese women with metabolic syndrome","volume":"8","author":"Olszanecka-Glinianowicz","year":"2012","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jpag.2014.08.007_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2362.2011.02586.x","article-title":"Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome","volume":"42","author":"Lajunen","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jpag.2014.08.007_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1684\/ecn.2011.0279","article-title":"Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome","volume":"22","author":"Cekmez","year":"2011","journal-title":"Eur Cytokine Network"},{"key":"10.1016\/j.jpag.2014.08.007_bib34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1749-6632.2010.05652.x","article-title":"Diagnosis and management of hirsutism","volume":"1205","author":"Escobar-Morreale","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jpag.2014.08.007_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2014.08.007_bib36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1523-1747.2003.12244.x","article-title":"Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1)","volume":"120","author":"Thiboutot","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jpag.2014.08.007_bib37","first-page":"2854","article-title":"Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features","volume":"81","author":"Morales","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jpag.2014.08.007_bib38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/edrv.20.4.0374","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jpag.2014.08.007_bib39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jpag.2014.08.007_bib40","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2006-2002","article-title":"Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls","volume":"92","author":"McCartney","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318814003052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318814003052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:41:40Z","timestamp":1761054100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083318814003052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1083318814003052"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2014.08.007","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Visfatin Levels in Adolescents with Polycystic Ovary Syndrome: A Prospective Case-Control Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2014.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}